The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic Encephalopathy
2024 · Value in Health · 2 citations
https://doi.org/10.1016/j.jval.2024.12.004